Catalyst Wire Dossier Catalyst Wire Dossier

RBT-3

· Renibus Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RBT-3, covering 2020-03-03 to 2020-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease [Phase 1]

See pricing